Skip to Main Content

Paper Details

Three-Year Efficacy and Safety of the Misago Peripheral Stent for Superficial Femoral Artery Disease: Final Results from the OSPREY Trial.
J Vasc Interv Radiol
0
2020
Author NameAffiliation
Michael R JaffNewton-Wellesley Hospital
Jeffrey J PopmaBeth Israel Deaconess Medical Center, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2